Abstract: The occurrence of anemia in older adults has been associated with adverse outcomes including functional decline, disability, morbidity, and mortality. It is not clear to what extent these outcomes are the result of the anemia or concurrent illness. We performed a crosssectional, observational study to determine whether lower hemoglobin concentrations in older adults are associated with reduced health-related quality of life, functional status, depression, disability, and physical strength, independent of chronic disease. Three sites participated in this research: an academic geriatric practice, a hospital-based geriatric outpatient unit, and a community-based multispecialty internal medicine group. Health-related quality of life and functional status were measured using the Short Form-36 Health Survey (SF-36) and the Functional Assessment of Chronic Illness Therapy-Anemia (FACIT-An). Disability and depression were assessed using the Instrumental Activities of Daily Living (IADL) and the Geriatric Depression Scale (GDS) questionnaires, respectively. Handgrip strength was used as a physical performance measure. Anemia was defined as hemoglobin G13 g/dL for men or G12 g/dL for women. The mean SF-36 physical health component summary scores were 38.9 (with anemia) and 44.1 (without anemia) (p G 0.001). Anemia was associated with greater fatigue (p G 0.001), lower handgrip strength (p = 0.014), increased number of disabilities (p = 0.005), and more depressive symptoms (p = 0.002). Multivariate regression analysis, adjusted for demographic and clinical characteristics, demonstrated strong associations for reduced hemoglobin, even within the Bnormal[ range, and poorer health-related quality of life across multiple domains. Thus, anemia was independently associated with clinically significant impairments in multiple domains of healthrelated quality of life, especially in measures of functional limitation. Mildly low hemoglobin levels, even when above the World Health Organization (WHO) anemia threshold, were associated with significant declines in quality of life among the elderly. 
INTRODUCTION
A n increase in the elderly population is expected due to the high birth rates that occurred in the 1940s and 1950s and an increase in life expectancy. 24 In 2000, approximately 35 million people in the United States were aged 65 years and older; by 2050, this figure will rise to approximately 80 million. The population of individuals aged 85 years and older will grow approximately 5-fold by 2050. 13 Thus, the impact of common problems in the elderly, such as chronic illness and disability, will have profound implications for healthcare in the future.
Anemia (hemoglobin EHb^G12 g/dL in women and G13 g/dL in men) is common in people over the age of 65 years, occurring in 10% of those living in the community 20 and in more than 50% of those living in institutions. 4, 30, 38 Although aging alone is not a cause of anemia, 9 it has been proposed that either a reduction in hematopoietic reserve or dysregulation of the factors that modulate hematopoiesis predisposes older individuals to anemia during hematopoietic stress.
The explanation for why anemia is so much more common in the elderly is not fully established. Certainly factors such as iron deficiency and concurrent inflammatory disease are more prominent in the elderly, but one must also factor in the presence of age-associated renal impairment, endocrine insufficiency, nutritional inadequacy, and myelodysplasia as potential contributors. For one-third to one-half of anemic elderly, a specific cause for the anemia is not readily apparent (Bunexplained anemia[); 3, 20 defining the pathogenesis in these cases is the focus of much current research. Inflammatory pathways, including hepcidin, have been implicated under certain circumstances. 18, 19 Bone marrow stem cell proliferative capacity also declines somewhat with age, 14, 26, 43, 44 but experiments in laboratory animals suggest that this decline alone would be insufficient to result in anemia. 21Y23 However, myelodysplasia does increase in frequency with advancing age, 41 and in some cases this bone marrow disorder presents as anemia without white blood cell or platelet abnormalities apparent on the peripheral blood smear. Thus, some cases of unexplained anemia may ultimately be attributed to myelodysplastic syndrome, although it is unclear how large this component is. Considering the one-third or more of elderly patients with anemia but no distinct explanation for the anemia, it is likely that they have a composite of several contributing factors.
Over the past 10 years several studies have defined the untoward consequences of anemia in the elderly. These include increased risk of falls, 31, 36 weakness, 33, 34 and immobility. 10 The InCHIANTI study, based on data from a population base of 1156 individuals aged 65 years and older from the Chianti region of Italy, demonstrated that anemia was associated with disability and decreased physical performance using handgrip and kneeextensor strength tests. 8, 34 Furthermore, longitudinal studies have demonstrated increased mortality among individuals with even mild anemia. 11, 15, 25 A recent retrospective cohort study of the Veterans Affairs National Surgical Quality Improvement database indicated that of 310,311 patients aged 65 years and older who underwent noncardiac surgery, the 30-day mortality and cardiac event rates increased by 1.6% for each 1% change in hematocrit below the level of 39%. 54 Thus, although in younger individuals mild anemia may be well tolerated, in older individuals it is associated with important negative consequences.
Although previous studies focusing on older patients have demonstrated the importance of anemia on these clinical and functional outcomes, to our knowledge health-related quality of life has not been comprehensively evaluated. Accordingly, we embarked on the current study to evaluate the association of anemia with measures of health-related quality of life and functional status.
METHODS

Study Design
We performed a multicenter, cross-sectional survey of older patients cared for in an outpatient setting. All study procedures were approved by the institutional review board of each center, and all patients provided informed consent.
Patients were enrolled in 1 of 3 institutions in the United States: the Institute for Advanced Studies in Aging and Geriatric Medicine, Washington, DC; Sarasota Hospital, Sarasota, Florida; and the University of Utah School of Medicine, Salt Lake City, Utah. Total study time was 1 year from identification of the population to the completion of study of the last patient.
Patient Characteristics
Patients provided consent to have their medical records reviewed. Data abstracted from charts included date of birth, sex, eligibility criteria, and medical history pertaining to study criteria. Age was calculated from date of birth to date of enrollment. Height and weight were directly measured. Body mass index was estimated by weight (kg) divided by height (m) squared. Diagnoses and racial category were recorded from the chart history and patient report including prescribed medication for disease management. The presence or absence of specific conditions was recorded, including diabetes mellitus, rheumatoid arthritis, hypertension, or other chronic inflammatory conditions. Chronic inflammatory conditions include cardiovascular (class III or IV New York Heart Association congestive heart failure, myocarditis, pericarditis, vasculitis), any acute or chronic infection, respiratory (hypersensitivity pneumonitis, eosinophilic pneumonitis, bronchiectasis, chronic bronchitis, pleuritis), renal (chronic renal insufficiency Ecreatinine 91.5 mg/dL in men, 91.2 mg/dL in women^, glomerulonephritis, acute interstitial nephritis), gastrointestinal (esophagitis, inflammatory bowel disease ECrohn disease, ulcerative colitis^, diverticulitis, appendicitis, hepatitis, acute pancreatitis, cholecystitis), immunemediated (lupus, scleroderma, Sjögren syndrome, ankylosing spondylitis, Reiter disease, psoriatic arthritis, Be0het syndrome, dermatomyositis, polymyositis, myositis), or other such conditions. Smoking history was categorized into 3 groups: current (presently smoking), former (smoking a minimum of 100 cigarettes in a lifetime but not presently), and never (no history of smoking).
Patients were enrolled if they were aged 65 years and older; had no previous diagnosis of cancer (other than basal cell carcinoma of the skin), underlying blood disorder (for example, myelodysplasia), or end-stage renal failure (or prior renal transplant); and had not recently (within 3 mo) received blood transfusion or erythropoietin therapy. Patients were required to be able to read and speak English in order to complete the patient self-assessment questionnaires. In total, 333 participants were enrolled in the study. Of these, 5 patients had missing Hb data and were therefore excluded from the analysis. We present data on 328 patients.
Health-Related Quality of Life and Functional Status Outcomes
We used performance-based assessments along with patient self-reports to evaluate comprehensively the patient_s health status and the effects of anemia. The quality of life was based on 2 instruments: the Short Form-36 Health Survey (SF-36) 48, 50 and the Functional Assessment of Chronic Illness TherapyAnemia (FACIT-An). 5 The SF-36 questionnaire is a validated, generic healthrelated quality of life instrument that consists of 8 health concept domains: physical functioning (PF), role limitations due to physical health problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH). From these individual subscales, 2 overall scores were generated: physical health component (PCS) and mental health component (MCS). The first 5 subscales (PF, RP, BP, GH, VT) produce the physical health component score and the last 5 subscales (GH, VT, SF, RE, MH) produce the mental health component score; the GH and VT subscales overlap between the 2 overall components. The scoring for the 8 domains and the 2 overall components are based on a 0Y100 scale, with a higher value corresponding to a better quality of life. The SF-36 questionnaire has been extensively validated in numerous populations. 27, 29, 32 The FACIT-An questionnaire is specifically designed for anemia of chronic illness. 5, 7, 55 The FACIT-An includes 2 subscales; fatigue and non-fatigue, with 13 and 7 questions, respectively. The overall anemia score is generated by combining the scores from all 20 questions. For the fatigue subscale, the minimum possible score is 0 and the maximum is 52; for the non-fatigue subscale, the range is 0Y28. Hence, the minimum overall anemia score is 0 and the maximum is 80. A higher score corresponds to a better state of health and functioning. The FACIT scales have been shown to be valid and reliable. 55 
Disability, Depression, and Strength Outcomes
Disability in basic activities of daily living was assessed by the Instrumental Activities of Daily Living (IADL) questionnaire. 28 The instrument consists of 13 questions: 6 questions about the respondent_s ability to perform basic activities of daily living (eating, bathing, dressing, using the toilet, personal grooming, walking, and getting in and out of bed), and 7 questions about instrumental activities of daily living (preparing meals, using the telephone, shopping, doing housework, taking medications, and handling one_s own money). 28 The possible responses to each question are that the activity can be performed without help, with some help, or that the respondent is completely unable to perform the activity (complete help needed). Disability for a particular activity was defined as needing either partial or complete help.
Depression was assessed using the Geriatric Depression Scale (GDS) questionnaire. 56, 57 The GDS was designed to measure the symptoms of depression among elderly patients, and has been validated extensively in psychiatric settings. The questionnaire consists of 15 questions evaluating outlook and satisfaction with life, energy and activity levels, and memory. For each of the questions, the patient is asked how he or she felt over the past week. The possible responses to each question are Byes[ or Bno[ (for example, BAre you basically satisfied with your life?[). For each patient, the total number of answers indicating depression was computed to generate the GDS score. Although differing sensitivities and specificities have been obtained across studies, for clinical purposes a score greater than 5 points suggests a diagnosis of depression. 57 The study also quantified physical performance through handgrip strength with a handheld dynamometer (in kg), using the mean value after performing the task 3 times. Previous studies demonstrated that handgrip strength has predictive validity for subsequent disability and mortality in older women. 37 
Laboratory Analysis
Laboratory analysis from blood included Hb, hematocrit, white blood cell count, platelet count, red blood cell indices, serum iron, total iron binding capacity, erythropoietin, vitamin B 12 , and serum creatinine. All laboratory tests were performed centrally by LabCorp (Raritan, NJ). Questionnaires and measurements were performed within 1 month of serum Hb measurement.
Anemia was defined by Hb levels below 13 g/dL for men and below 12 g/dL for women, according to World Health Organization (WHO) criteria. 53 The WHO definition was previously shown to be suitable for defining anemia in older persons. 20, 25 
Statistical Analysis
The primary objective of this analysis was to determine the independent influence of anemia on health-related quality of life. For univariate comparisons, t tests were used for continuous variables and chi-square tests were used for categorical variables. To ascertain the influence of Hb concentration on other health status outcomes, we used analysis of variance to assess the effect of Hb on outcomes variables. Kernel density estimation was used to explore the functional relationship of Hb concentration on outcomes measures. 46 Statistical analyses were performed using S-PLUS (version 6.2) and SAS (version 8) statistical software.
In subsequent analyses, Hb was categorized by increments of 1 g/dL: G12, 12Y12.9, 13Y13.9, 14Y14.9, and Q15 g/dL. To adjust for potential confounding variables we used analysis of covariance (ANCOVA) with Hb category as a main effect while adjusting for age, sex, race, and comorbid conditions (diabetes mellitus, rheumatoid arthritis, hypertension, and chronic inflammatory conditions). Main effects were considered statistically significant if the p-value was less than 0.05. We also investigated whether interaction effects (Hb with age E975 yr^or sex) were present using a significance level of 0.10. If main effects were statistically significant, pairwise t tests were calculated using the Hb Q15 g/dL as the reference group. We tested for linear trends using ordinal Hb scores across the Hb categories.
United States population norms for the SF-36 are available for sex-and age-matched cohorts. 47 We created a binary variable for each patient that indicated if his or her quality of life score was above or below the United States population norm for that patient_s age-and sex-matched sample. Logistic regression analysis was used to determine the independent effect of low Hb on the likelihood of patients having quality of life worse than Table 1 shows the characteristics of study patients stratified by Hb categories. Of the 328 patients, 64% were women. The mean (standard deviation ESD^) age was 76.8 (7.1) years, ranging from 65 to 103 years. The mean Hb was 13.2 (1.5) g/dL, with mean values of 12.9 g/dL for women and 13.8 g/dL for men (p G 0.001). Patients aged 75 years and older tended to have lower Hb values with a mean of 12.8 g/dL compared to the 13.3 g/dL of the cohort aged 65Y74 years (p G 0.001). Ninety (27%) patients met the WHO criteria for anemia: 54 (26%) women and 36 (31%) men.
RESULTS
Patient Characteristics
The mean (SD) body mass index was 27.6 (6.2) kg/m 2 . The racial distribution was 92% white, 2% African-American, and 6% who reported Bother.[ Five percent were current smokers, 46% were former smokers, and 49% were never smokers. The following chronic disease states had been diagnosed at the time of enrollment: diabetes (14%), rheumatoid arthritis (16%), hypertension (61%), and chronic inflammatory conditions (43%). One hundred thirty-two (40%) patients reported only 1 chronic disease state, 126 (38%) reported 2, 15 (4%) reported 3, and 3 (1%) patients reported all 4 disease states.
Compared to the patients without anemia, patients with anemia were older on average (p G 0.001), and were more likely to report hypertension (odds ratio EOR^, 2.1; p = 0.006) and twice as likely to report hospitalizations in the past year (OR, 2.1; p = 0.016). Those with anemia reported more chronic health conditions than patients without anemia (17% increase; p = 0.003).
Quality of Life and Functional Status
Univariate Analysis (Unadjusted)
The unadjusted mean SF-36 physical health component score was 47.1 for patients with Hb of 15 g/dL and higher, and 37.3 for patients with Hb below 12 g/dL (p G 0.01) ( Table 2 ). This decreasing trend in physical health component score was apparent across the Hb categories (p for trend G 0.001), and was also evident among the 5 physical function subscales. Trends of the association between Hb level and quality of life scores were also significant for the overall FACIT-An score (p for trend G 0.001) and its fatigue component (p for trend G 0.001), as well as for the GDS (p for trend G 0.001), IADL (p for trend G 0.001), and handgrip strength (p for trend G 0.001).
The unadjusted mean SF-36 physical health component score was 38.9 and 44.1 (p G 0.001) for patients with and without anemia, respectively. Significant differences were also observed for the 5 underlying subscales (Figure 1 ). Significant differences between patients with anemia and patients without anemia were found for all the FACIT scales: the overall (p = 0.004), non-fatigue (p = 0.01), and fatigue (p G 0.001) scales (Figure 2 ). The mean (SD) number of disabilities was 2.0 (2.9) activities for patients with anemia and 1.0 (1.9) for patients without anemia (p = 0.005). Fiftyseven (63%) patients with anemia and 101 (43%) patients without anemia indicated at least 1 disability (p G 0.001). Fifty-three (59%) patients with anemia and 103 (44%) of the patients without anemia indicated depression in at least 2 symptoms by GDS (p = 0.002). The mean (SD) number of symptoms indicating depression was 3.1 (3.1) for patients with anemia and 2.0 (2.7) for patients without anemia (p = 0.002). Patients with anemia had a significantly lower handgrip strength than patients without anemia (21.3 vs. 24.1kg; p = 0.014) (Figure 2 ).
Multivariate Analysis (Adjusted)
Multivariate regression analysis adjusted for age, sex, weight (for handgrip strength only) and presence of diabetes, hypertension, chronic inflammation, or rheumatoid arthritis, confirmed strong associations with declining Hb and poorer health-related quality of life (Table 3 ). The adjusted mean loss of handgrip strength was 4.0 kg from the highest Hb category (Hb Q15 g/dL) to the lowest (Hb G 12 g/dL) (p G 0.01). Hb effects on handgrip strength were evident for Hb levels below 14 g/dL (p G 0.05). Some SF-36 measures (GH, VT, and MH) showed significantly lower adjusted scores for Hb below 15 g/dL, when compared to patients with Hb above 15 g/dL; for example, the mental health scores dropped approximately 10 points for patients with mean Hb below 15 g/dL (p G 0.01). Lower Hb levels were associated with an adjusted decrease of more than 6 points in the physical health component score (p for trend = 0.002).
Population-Based Comparisons
The independent association of lower Hb levels with lower quality of life measures is supported by comparison of physical health component score and mental health component score using population norms 30 (data not shown). Patients with Hb below 13 g/dL were between 2.5 to 3.5 times (depending on their Hb category) more likely to report a physical health component score lower than their age-and sex-matched peers, as compared to patients with Hb above 15 g/dL. Patients with Hb below 13 g/dL were approximately 3.5 times more likely to report a lower mental health component score for the SF-36 than their age-and sexmatched peers.
DISCUSSION
In the current observational study we examined the correlation of Hb and quality of life among community-based elderly patients. We determined not only that anemia was associated with a lower quality of life, but also that a trend for reduced quality of life began for Hb levels as they fell below 15 g/dL. Our analyses showed that anemia, independent of chronic disease, represents a risk factor for depression and disability. Furthermore, we observed a significant association of anemia with declines in health-related quality of life, functional status, and physical strength.
Anemia is commonly defined according to medical discipline. For example, the National Kidney Foundation defines anemia as Hb levels below 12 g/dL in adult males and postmenopausal females, 1 whereas cancer and chemotherapyassociated anemia is defined by the National Comprehensive Cancer Network by a Hb level of less than 11 g/dL. 40 In the current study, we defined anemia in accordance with WHO criteria of Hb levels less than 13 g/dL for men and less than 12 g/dL for women. 53 This definition establishes a high threshold for the anemia diagnosis, and therefore could result in the inclusion of asymptomatic individuals in the anemia group. This concern notwithstanding, we defined 2 groups (anemic and not anemic) with an overall difference in mean Hb of 2.3 g/dL and found quality of life was significantly lower for those in the anemia group.
In an attempt to provide a more comprehensive description of the effects of anemia on quality of life, data were stratified by Hb levels. Further analysis disclosed that quality of life measures progressively declined in groups with lower Hb concentrations, even for Hb levels higher than the WHO definition for anemia. Even after adjustment for demographic differences and comorbid conditions, SF-36 measures of vitality, general health, and mental health showed a significant decline for patients with mean Hb levels below 15 g/dL. The handgrip strength assessment revealed that significant reductions in grip strength were evident even for Hb concentrations below 14 g/dL. These findings, combined with prior data indicating inferior survival for reduced Hb concentration even in the nonanemic range, suggest that Hb concentrations traditionally considered normal may have untoward consequences for the elderly with respect to health-related quality of life and functional performance. 11, 25 The physical symptoms associated with anemia are possibly explained by reduced exercise tolerance. 35 Affected individuals often experience fatigue and may be consequently less active, with a sedentary lifestyle resulting in muscle wasting (sarcopenia), falls, and diminished cardiovascular fitness that further reduce exercise tolerance. Poor muscle oxygenation and reduced physical strength associated with lower Hb levels may also affect quality of life and functional outcomes. In this study, handgrip strength was used a measure of physical strength. After adjusting for differences in weight, the anemia-related decline in handgrip strength of 1.7 kg was equivalent to aging approximately 4 years according to the multivariate linear regression model (data not shown). The effect of anemia on physical strength was particularly significant for men. Anemia has been shown to be more prevalent in men than in women beyond the age of 70 years. 20 This may be the result of declining testosterone levels (andropause) in this age-group, as hypogonadal levels are associated with modest (0.5Y0.8 g/dL) declines in Hb level. 16, 52 The SF-36 is perhaps the most widely used instrument for measuring health-related quality of life. The decrease in physical component scores associated with anemia is consistent with individuals who have greater limitations in self-care and physical, social, and emotional role activities; body pain; frequent tiredness; and who are more likely to rate their overall health as Bpoor.
[ 49 In the current study, anemia and lower Hb levels were associated with clinically meaningful differences in SF-36 scores. The SF-36 physical component score effect size for individuals with anemia is similar to the physical health component score measured for individuals with myocardial infarction in the past 12 months or chronic obstructive pulmonary disease in other studies. 12, 32, 45, 49, 51 Patients with Hb levels below 12 g/dL were 3.5 times more likely to have a physical health component score measured lower than their ageand sex-matched peers in the United States population, 47 when compared with individuals with Hb above 15 g/dL.
Penninx and colleagues 33Y35 reported on the impact of anemia on physical function in 2 distinct cohorts of elderly individuals. In these studies, they found that anemia was associated with negative effects on physical performance and strength. Anemia is associated with a 3-fold increase in the risk of falls; the risk was comparable to a fall risk for those with arthritis.
Studies have also demonstrated diminished physical function with lower Hb levels that are above the WHO anemic threshold. 10, 33 The current study extends those findings by demonstrating a significant decline in physical strength as well as significant levels of disability and diminished quality of life as reported by the elderly.
The present study is limited in a number of ways. Since it is a cross-sectional survey, we were unable to measure longitudinal changes in Hb or long-term implications of persistently low Hb, and because the study population does not include sufficient numbers of minority patients, the results should not be generalized to all racial groups. Additionally, due to the observational nature of the study, we cannot exclude the possibility of unmeasured confounding influences (that is, that other factors associated with anemia that we did not measure may have caused the poor clinical outcomes). However, the association of lower Hb levels persisted even after multivariate analysis adjusted for differences in demographic and disease characteristics. While interventional trials may be required to confirm the independent influence of anemia (or anemia correction) in this population, significant data exist in other cohorts demonstrating improved quality of life with pharmacologic interventions aimed at reversing anemia, 6, 17, 42 including in geriatric patients. 2 In the present study, we used validated patient self-administered questionnaires to reduce the possibility of introducing questionnaire-based bias. By using these standardized measures we were also able to compare the effects of anemia in the elderly with other well-known diseases, and with age-and sex-matched norms, again confirming the association of lower Hb values and reduced quality of life.
Our findings indicate that anemia is associated with poor health-related quality of life, functional decline, low muscle strength, more disability, and more depression. Men may experience greater physical effects of lower Hb, and higher age and the presence of comorbidities corresponded with poorer quality of life and functional performance. Moreover, we demonstrated that adverse outcomes in the elderly occur at higher Hb levels than the anemia thresholds established by the WHO. The downward spiral of reduced exercise capacity resulting from anemia may ultimately contribute to both dependency and depression, both of which are components of the frailty syndrome. 39 
